-Tehelka With 65 percent of the population below the age of 35, India boasts of an unparalleled generational dividend, but are we turning this potential into a disaster? Avalok Langer spots a ticking time bomb Nutrition & Health* 40% of children in India are malnourished 43% of children in the age group of 12-23 months receive full immunisation 48%+ of children are underweight 50%+ of all deaths under age 5 are related to malnutrition 45% of children...

-The Economic Times Tribal affairs minister Kishore Chandra Deohas reportedly written to the governors of nine states asking them to cancel mining concessions granted in violation of the law. The Forest Rights Act of 2006 mandates the permission of the gram sabha of a tribal community for using their habitat for purposes other than customary use. So, if mining leases have been granted without the permission of gram sabhas on tribal land,...

-The Hindu A NABARD survey says middlemen funded by banks have kept growers captive to high-interest loans Jammu: Kashmir's acres of undulating apple orchards may soon be waste lands, a survey by the National Bank for Agriculture and Rural Development (NABARD) accessed by The Hindu shows. The Rs. 4,000-crore industry has been brought to its knees by a network of middle-order market functionaries comprising pre-harvest contractors (PHCs), commission agents (CAs) and wholesalers...

-Civil Society Online Accreditation is the act of granting credit or recognition. It is to be preceded with a process where facts, figures and professional ethics are scrutinized so that the desired certification of competency, authority or credibility is presented. Only the best suited with the requisite track record are to find themselves in the approved list. In India, the much talked about and well critiqued initiative wherein consultants undertaking the responsibility...

-The Economic Times WASHINGTON: Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject patent claims of the drug maker Novartis for its celebrated cancer medicine Glivec reverberated across the world. The pharma lobby railed against the decision but the overwhelming sentiment, from physicians to politicians, from academia to media, particularly in a country groaning from the high cost of health care,...